Back to News
Market Impact: 0.45

See Which Of The Latest 13F Filers Holds JNJ

JNJNDAQSPYSTRA
Market Technicals & FlowsInvestor Sentiment & Positioning
See Which Of The Latest 13F Filers Holds JNJ

Hedge funds significantly increased their aggregate holdings in Johnson & Johnson (JNJ) during the quarter ending March 31, 2025. An analysis of 165 funds reveals a collective 85.15% increase in JNJ share count, with holdings rising by 6,877,715 shares to a total of 14,955,245 from December 31, 2024. This substantial accumulation by institutional investors suggests growing conviction in JNJ, despite the inherent limitations of 13F filings which only disclose long positions.

Analysis

Institutional sentiment towards Johnson & Johnson (JNJ) turned markedly positive during the first quarter of 2025, as evidenced by a significant increase in aggregate holdings reported in 13F filings. An analysis of 165 funds revealed a collective 85.15% increase in JNJ share count, with total holdings rising by 6.88 million shares to 14.96 million from the period ending 12/31/2024. This broad-based accumulation points to growing conviction among fund managers. A more granular look at a recent batch of 20 filers supports this trend, showing a net increase of 23,651 shares, with six funds adding to their positions versus five that trimmed their stakes. While it is crucial to acknowledge that 13F filings only disclose long positions and may not capture complex hedging or bearish strategies, the sheer scale of the aggregate increase in holdings provides a strong signal of bullish institutional flows into the stock.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.55

Ticker Sentiment

JNJ0.80
NDAQ0.00
SPY0.00
STRA0.00

Key Decisions for Investors

  • Investors should interpret the 85.15% quarter-over-quarter increase in aggregate fund ownership as a strong bullish indicator, suggesting institutional capital is rotating into Johnson & Johnson.
  • Given that this analysis is based purely on fund flows, it is imperative to conduct fundamental due diligence on JNJ's recent performance, pipeline developments, and management outlook to validate the thesis suggested by this institutional buying.
  • Traders should consider this positioning data as a starting point for further research, remaining mindful that 13F filings do not reflect short positions or derivatives that could be part of a broader, more complex investment strategy.